World Antibody Focus 2013

World Antibody Congress 2013 is set to be the region’s most prestigious industry conference where ideas, intelligence and relationships really make a difference. Globally inviting 300+ industry heavyweights from leading pharmas, biotechs, research institutions, government authorities and solution providers to discuss the industry redhots such as Antibody-drug conjugate, Biosimilar and Biobetters, Regulatory Affairs & Antibody Therapeutics, Antibody Engineering & Design, Pre-Clinical and Clinical Development, Production & Protein Development, etc . World Antibody Congress 2013 will serve as a strategic platform for antibody leaders just like you to share key strategies for expediting business development, scientific advancement and partnerships for their antibody business.

Benefits of Participation-Why You Can’t Miss WAF2013:
• Enjoying worldwide publicity with WAF2013 global advertising & promotion campaign
• Meeting and greeting: understanding clients’ changing business needs
• Distributing permanent reminders of your products or services at WAF2013
• Receiving prominent speaking slots to address an audience of top executives and potential clients
• Exhibiting to showcase your latest antibody technologies and advanced solutions
• Holding one-to-one meetings with top prospects and promoting your products/services to potential clients during and after WAF2013

Early Confirmed and Invited Speaker Faculty Includes:
• Sean E. Harper, Executive Vice President, R&D, Amgen
• GUO Ya Jun, Director, Chinese National Engineering Research Centre for Antibody Medicine
• Hal Barron, Executive Vice President and Chief Medical Officer, Global Development, Genentech
• William Strohl, Vice President, Biologics Research, Johnson & Johnson
• Bahija Jallal, Executive Vice President, R&D, Medimmune
• Patrick Baeuerle, Chief Scientific Officer, Senior Vice